Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from was processed by Pulse News Wire on January 30, 2026. It represents a primary source document for Japanese Earnings sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
Source disclosure: January 30, 2026 EIKEN CHEMICAL CO.,LTD. [4549.T] TOKYO, Jan 30 (Pulse News Wire) – Eiken Chemical CO.,LTD. (4549.T) reported a revenue increase for the third quarter ending March 2026, driven by higher sales of fecal immunochemical test reagents and medical devices, particularly overseas. Despite rising raw material costs and geopolitical risks, the company maintained its full-year earnings forecast unchanged due to cost efficiency measures and gains from the sal